Filter News
Area of Research
- (-) Neutron Science (16)
- (-) Nuclear Science and Technology (5)
- Advanced Manufacturing (1)
- Biological Systems (1)
- Biology and Environment (38)
- Building Technologies (1)
- Clean Energy (45)
- Computer Science (3)
- Energy Sciences (1)
- Fusion and Fission (3)
- Fusion Energy (3)
- Isotopes (2)
- Materials (34)
- Materials for Computing (3)
- National Security (14)
- Quantum information Science (3)
- Supercomputing (58)
News Topics
- (-) Artificial Intelligence (2)
- (-) Bioenergy (6)
- (-) Biomedical (9)
- (-) Composites (1)
- (-) Computer Science (8)
- (-) Microscopy (1)
- (-) Sustainable Energy (3)
- 3-D Printing/Advanced Manufacturing (8)
- Advanced Reactors (8)
- Big Data (2)
- Biology (1)
- Biotechnology (1)
- Chemical Sciences (1)
- Clean Water (1)
- Climate Change (1)
- Coronavirus (7)
- Cybersecurity (1)
- Decarbonization (2)
- Energy Storage (1)
- Environment (3)
- Fossil Energy (1)
- Fusion (6)
- High-Performance Computing (1)
- Isotopes (5)
- Machine Learning (2)
- Materials (7)
- Materials Science (14)
- Mathematics (1)
- Molten Salt (4)
- Nanotechnology (8)
- National Security (1)
- Neutron Science (55)
- Nuclear Energy (25)
- Physics (5)
- Polymers (1)
- Quantum Science (3)
- Security (1)
- Space Exploration (3)
- Summit (5)
- Transformational Challenge Reactor (3)
- Transportation (3)
Media Contacts
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.